Historical record - last NADAC publication: 8/23/2023

Product Information

ATORVASTATIN 20 MG TABLET is a generic product labeled by Cipla USA Inc., priced at $0.0398 per EA under NDC 69097094512. Its NADAC has been published 294 times since Jan 10, 2018.

The High Outlier badge above means this manufacturer's average price in the ATORVASTATIN CALCIUM market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.

ATORVASTATIN 20 MG TABLET

ATORVASTATIN CALCIUM
$0.0398per EA
High Outlier

Strength

20 mg/1

Manufacturer

Cipla USA Inc.

NDC

69097094512

Classification

Generic

Dosage Form

TABLET, FILM COATED

Route

ORAL

Last Updated

8/23/2023

Approval Type

Generic (ANDA)

FDA Application

ANDA205519

On Market Since

11/16/2017

Pharmacological Classes

HMG-CoA Reductase Inhibitor
Hydroxymethylglutaryl-CoA Reductase Inhibitors

Price Statistics

The NADAC for ATORVASTATIN 20 MG TABLET has been published 294 times since Jan 10, 2018, and over the history we have for it it has declined 50.0%. The table below summarizes its recorded NADAC range and movement.

Current price$0.0398 per EA
All-time high$0.0889 (Jul 10, 2019)
All-time low$0.0371 (Dec 21, 2022)
Median price$0.0648
Average price$0.0636
Largest weekly change+24.2% (May 22, 2019)
Weeks tracked294
Tracking sinceJan 10, 2018

Price History

1W

0.0%

1M

0.0%

3M

0.0%

6M

0.0%

1Y

0.0%

3Y

-4.5%

5Y

-26.9%

All

-50.0%

Generic Alternatives

The matcher finds 10 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 10 manufacturers (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 28% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of ATORVASTATIN 20 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for ATORVASTATIN 20 MG TABLET, manufactured by Cipla USA Inc., is $0.0398 per EA (NDC 69097094512), effective Aug 23, 2023.

How has the price of ATORVASTATIN 20 MG TABLET changed over time?

Over the history we have for it, the NADAC for ATORVASTATIN 20 MG TABLET has declined 50.0%. It has been tracked across 294 weekly CMS publications since Jan 10, 2018.

What are the highest and lowest recorded NADAC prices for ATORVASTATIN 20 MG TABLET?

Since Jan 10, 2018, the NADAC for ATORVASTATIN 20 MG TABLET has ranged from a low of $0.0371 (Dec 21, 2022) to a high of $0.0889 (Jul 10, 2019), with a median of $0.0648 per EA.

Are there cheaper alternatives to ATORVASTATIN 20 MG TABLET?

Yes. 10 NADAC-published products share the same active ingredient, strength, and dosage form. The lowest-priced option, ATORVASTATIN 20 MG TABLET, is $0.0285 per EA — about 28% below ATORVASTATIN 20 MG TABLET.

Who manufactures ATORVASTATIN 20 MG TABLET?

ATORVASTATIN 20 MG TABLET (NDC 69097094512) is labeled by Cipla USA Inc., and CMS classifies it as a generic product.